Search results for " biosimilars" in Articles / App Notes
Article
Optimizing your Cell Culture Process to Improve Productivity
Jeanne Linke Northrop: What industries would need these analytical testing for cell culture?
Mary Szorik: We mainly work with biopharma companies that are producing therapeutic proteins, biosim…
Article
Pandemic Alters Policies and Practices for Drug Development and Regulation
There were important advances in biosimilars, moreover, with the approval of the first two interchangeable products (1).
Despite these accomplishments, FDA officials had to contend with publ…
Article
Maximum Output Starts with Optimized Upstream Processing
Demand for biosimilars is also increasing. The requirements associated with COVID-19 vaccine manufacturing are placing further pressure on upstream manufacturing capacities.
“The situation is evol…
Article
2019’s Top Bioprocessing Trends and What to Expect in 2020
…the Quality of Your mAbs?
Supply Chain Challenges for Single-Use Systems
The Good and Bad of Biosimilars
Getting it Right from the Start in the Drug Development Process
Monitoring and…
Article
Tools and Processes for Mature and Emerging Therapies
Emerging therapies
As biologic drugs mature and biosimilars move to market, bioprocessing technologies are expected build on current technologies to improve efficiencies. For emerging therap…
Article
Nurturing Knowledge from Disparate Data Streams
Leveraging vast quantities of analytical data requires digitalization and platform integration.
By Cynthia A. Challener
jijomathai/stock.Adobe.comAnalytical instrument…
Article
Biopharmaceutical Process Development: 2018 Lessons and 2019 Predictions
Single-Use Technologies Are Still Growing—But Not Without Challenges
Single-use technology is said to offer a plethora of benefits in the production of biopharmaceuticals and biosimilars, includin…
Article
A Look at the Affinity Chromatography Landscape
The technology has also been used to develop chromatography resins for manufacturing of non-antibody biosimilars—such as FSH [follicle-stimulating hormone] and hCG [human chorionic gonadotropin]—and v…
Article
A Plastic Pipeline for Commercial Bioprocessing?
“That does not mean that stainless steel will not exist anymore,” he says; it will remain very important for largevolume products such as biosimilars.
For biopharma companies requiring up to 10…
Article
Preparing for the Future: Visions and Insights for Biomanufacturing
Yet, new market dynamics, such as growing competition from biosimilars and niche drugs targeting smaller patient populations, are reshaping how drugs are produced and sold.
To keep up with this c…